Advertisement

Advertisement

PCOWKIN Stock Latest News

OWKIN – Weekly Recap

Private CompaniesOWKIN – Weekly Recap

OWKIN Positions AI Platform to Capitalize on FDA’s Move Toward AI-Enabled Clinical Trials

PremiumPrivate Companies

OWKIN Positions AI Platform to Capitalize on FDA’s Move Toward AI-Enabled Clinical Trials

3d ago

OWKIN Highlights AI Platform Aimed at Accelerating Clinical Trial Timelines

PremiumPrivate Companies

OWKIN Highlights AI Platform Aimed at Accelerating Clinical Trial Timelines

3d ago

OWKIN Highlights New Benchmark for Subgroup Analysis in Oncology Trials

PremiumPrivate Companies

OWKIN Highlights New Benchmark for Subgroup Analysis in Oncology Trials

4d ago

OWKIN Highlights New Subgroup Analysis Benchmark for Oncology Trial Optimization

PremiumPrivate Companies

OWKIN Highlights New Subgroup Analysis Benchmark for Oncology Trial Optimization

4d ago

Owkin Highlights Open-Science Strategy and Ties to Hugging Face Ecosystem

PremiumPrivate CompaniesOwkin Highlights Open-Science Strategy and Ties to Hugging Face Ecosystem

5d ago

OWKIN Highlights AI-Centered Oncology Trends and Positions K Pro for Implementation Gap

Private Companies

OWKIN Highlights AI-Centered Oncology Trends and Positions K Pro for Implementation Gap

5d ago

Owkin Highlights Open-Science Contributions and AI Pathology Integration

Private Companies

Owkin Highlights Open-Science Contributions and AI Pathology Integration

5d ago

OWKIN Positions K Pro Platform at Center of Emerging AI Oncology Workflows

PremiumPrivate Companies

OWKIN Positions K Pro Platform at Center of Emerging AI Oncology Workflows

6d ago

Owkin Showcases K Pro AI Scientist Platform and Proprietary Biomedical Models

PremiumPrivate Companies

Owkin Showcases K Pro AI Scientist Platform and Proprietary Biomedical Models

6d ago

Owkin Showcases AI Scientist Platform K Pro and Proprietary Biology Models

PremiumPrivate Companies

Owkin Showcases AI Scientist Platform K Pro and Proprietary Biology Models

6d ago

Owkin Highlights Agentic AI Platform K Pro for Accelerated Drug Discovery

PremiumPrivate Companies

Owkin Highlights Agentic AI Platform K Pro for Accelerated Drug Discovery

7d ago

Owkin Highlights Agentic AI Platform K Pro for Accelerating Drug Discovery

PremiumPrivate CompaniesOwkin Highlights Agentic AI Platform K Pro for Accelerating Drug Discovery

7d ago

OWKIN Leverages Data Network, Academic Ties and Cloud Ecosystems to Advance K Pro AI Platform

Private Companies

OWKIN Leverages Data Network, Academic Ties and Cloud Ecosystems to Advance K Pro AI Platform

9d ago

Owkin Positions K Pro as Specialized Biopharma Layer on Hyperscaler AI Deals

Private Companies

Owkin Positions K Pro as Specialized Biopharma Layer on Hyperscaler AI Deals

10d ago

OWKIN Positions K Pro as Specialized AI Layer in Emerging Pharma Agent Ecosystem

PremiumPrivate Companies

OWKIN Positions K Pro as Specialized AI Layer in Emerging Pharma Agent Ecosystem

11d ago

Owkin Expands Clinical AI Research Through McGill Health Centre Partnership

PremiumPrivate Companies

Owkin Expands Clinical AI Research Through McGill Health Centre Partnership

11d ago

OWKIN Promotes K Pro AI Platform Engagement at Major Cancer Research Conference

PremiumPrivate Companies

OWKIN Promotes K Pro AI Platform Engagement at Major Cancer Research Conference

11d ago

OWKIN Deepens Academic Collaboration With McGill Research Institute to Support AI in Healthcare

PremiumPrivate Companies

OWKIN Deepens Academic Collaboration With McGill Research Institute to Support AI in Healthcare

11d ago

OWKIN Showcases K Pro Oncology AI Platform Engagement at AACR

PremiumPrivate CompaniesOWKIN Showcases K Pro Oncology AI Platform Engagement at AACR

12d ago

Owkin Emphasizes Patient Data Network and Oncology Database to Support AI Platform Strategy

Private Companies

Owkin Emphasizes Patient Data Network and Oncology Database to Support AI Platform Strategy

12d ago

OWKIN Gains Visibility at AWS Event With Focus on Oncology Data and AI Platform

Private Companies

OWKIN Gains Visibility at AWS Event With Focus on Oncology Data and AI Platform

13d ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >